Intrarenal B Cell Cytokines Promote Transplant Fibrosis and Tubular Atrophy

Area of Science:

• Immunology
• Transplantation Biology
• Renal Pathology

Background:

• Chronic allograft damage (CAD) is a major complication after kidney transplantation.
• B cells and tertiary lymphoid tissues are implicated in human renal allograft damage.

Purpose of the Study:

• To investigate the role of intra-allograft B cells in a murine model of chronic allograft damage (CAD).
• To assess the therapeutic potential of B cell depletion in mitigating CAD.

Main Methods:

• Murine renal transplantation model to induce CAD.
• Flow cytometry to characterize intra-allograft B cell populations (e.g., IgM(high) CD23(-), IgM(lo) CD23(+), IgM(lo) CD23(-)).
• B cell depletion using anti-CD20 antibody administered pre- or post-transplant.

Main Results:

• B cells formed tertiary lymphoid tissues with germinal centers within the allografts.
• B cell depletion post-transplant, but not pre-transplant, improved CAD.
• Intra-allograft B cells secreted key cytokines (GRO-α, RANTES, IL-6, MCP-1).
• B cell depletion reduced tubular loss, interstitial fibrosis, and collagen deposition.

Conclusions:

• Intra-allograft B cells are critical mediators of chronic allograft damage.
• Targeting B cells after kidney transplantation may be a viable therapeutic strategy to reduce CAD.